What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria

The best pharmacological treatment for each atrial fibrillation (AF) patient is unclear. We aim to exploit AF simulations in 800 virtual atria to identify key patient characteristics that guide the optimal selection of anti-arrhythmic drugs. The virtual cohort considered variability in electrophysio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of physiology Jg. 601; H. 18; S. 4013 - 4032
Hauptverfasser:	Dasí, Albert, Pope, Michael T.B., Wijesurendra, Rohan S., Betts, Tim R., Sachetto, Rafael, Bueno‐Orovio, Alfonso, Rodriguez, Blanca
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Wiley Subscription Services, Inc 01.09.2023 John Wiley and Sons Inc
Schlagworte:	Action Potentials - physiology Amiodarone Amiodarone - pharmacology Amiodarone - therapeutic use Atrial Fibrillation - drug therapy Atrium Calcium currents Cardiac arrhythmia Cardiovascular Clinical trials Drug therapy Electrophysiology Fibrillation Flecainide - pharmacology Flecainide - therapeutic use Heart Atria Humans Na+/K+-exchanging ATPase Patients Phenotyping Voltage atrial fibrillation ionic currents low voltage areas in silico drug trials
ISSN:	0022-3751, 1469-7793, 1469-7793
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!